Search research articles
Contact Us
Filters
Showing results (551-560 of 606) with videos related to
Page
of 61
Sort By:
American Journal of Respiratory Cell and Molecular Biology
|
June 21, 2003
The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor
Han Kim, Guo-Liang Xu, Alain C Borczuk, et al.
Drug and Alcohol Dependence
|
December 31, 2014
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter
Maarten E A Reith, Bruce E Blough, Weimin C Hong, et al.
Journal of Medicinal Chemistry
|
June 20, 1998
Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists
J B Thomas, S W Mascarella, R B Rothman, et al.
Medchemcomm
|
March 24, 2012
Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A
Katherine M Prevatt-Smith, Kimberly M Lovell, Denise S Simpson, et al.
Pharmacology, Biochemistry, and Behavior
|
November 1, 1994
Lack of evidence for context-dependent cocaine-induced sensitization in humans: preliminary studies
R B Rothman, D A Gorelick, M H Baumann, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
April 29, 2024
The Johns Hopkins Physician-Scientist Training Program to Enhance Institutional Retention and Entry Into Academic Positions: An Evaluation of Program Effectiveness and Outcomes
Jordina Rincon-Torroella, James Feghali, Albert Antar, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1995
Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranes
M L Silverthorn, C M Dersch, M H Baumann, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1995
Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate
R B Rothman, M L Silverthorn, M H Baumann, et al.
Bioorganic & Medicinal Chemistry
|
October 15, 2003
Diaryldimethylpiperazine ligands with mu- and delta-opioid receptor affinity: Synthesis of (+)-4-[(alphaR)-alpha-(4-allyl-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide and (-)-4-[(alphaR)-alpha-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide
In Jong Kim, Thomas Ullrich, James W Janetka, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 30, 2013
Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates
Michael H Baumann, Simon Bulling, Tova S Benaderet, et al.
Page
of 61
Search research articles
Search
Showing results (551-560 of 606) with videos related to
Sort By:
Page
of 61
American Journal of Respiratory Cell and Molecular Biology
|
June 21, 2003
The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor
Han Kim, Guo-Liang Xu, Alain C Borczuk, et al.
Drug and Alcohol Dependence
|
December 31, 2014
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter
Maarten E A Reith, Bruce E Blough, Weimin C Hong, et al.
Journal of Medicinal Chemistry
|
June 20, 1998
Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists
J B Thomas, S W Mascarella, R B Rothman, et al.
Medchemcomm
|
March 24, 2012
Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A
Katherine M Prevatt-Smith, Kimberly M Lovell, Denise S Simpson, et al.
Pharmacology, Biochemistry, and Behavior
|
November 1, 1994
Lack of evidence for context-dependent cocaine-induced sensitization in humans: preliminary studies
R B Rothman, D A Gorelick, M H Baumann, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
April 29, 2024
The Johns Hopkins Physician-Scientist Training Program to Enhance Institutional Retention and Entry Into Academic Positions: An Evaluation of Program Effectiveness and Outcomes
Jordina Rincon-Torroella, James Feghali, Albert Antar, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1995
Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranes
M L Silverthorn, C M Dersch, M H Baumann, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1995
Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate
R B Rothman, M L Silverthorn, M H Baumann, et al.
Bioorganic & Medicinal Chemistry
|
October 15, 2003
Diaryldimethylpiperazine ligands with mu- and delta-opioid receptor affinity: Synthesis of (+)-4-[(alphaR)-alpha-(4-allyl-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide and (-)-4-[(alphaR)-alpha-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide
In Jong Kim, Thomas Ullrich, James W Janetka, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 30, 2013
Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates
Michael H Baumann, Simon Bulling, Tova S Benaderet, et al.
Page
of 61